2013
DOI: 10.4244/eijv9i3a59
|View full text |Cite
|
Sign up to set email alerts
|

Gender differences in patients undergoing TAVI: a multicentre study

Abstract: TAVI can be an effective and safe strategy in high surgical risk patients, regardless of the gender; life-threatening bleedings were reported more frequently in female patients, being the only independent predictor of death.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
40
1

Year Published

2014
2014
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 58 publications
(42 citation statements)
references
References 22 publications
1
40
1
Order By: Relevance
“…Four studies [8][9][10][11], for a total of 3,065 patients, reported the unadjusted rates of early outcomes by sex. Women experienced higher rates of major vascular complications (12.0% vs 7.4%) and of major and life-threatening bleeding (21.0% vs 13.0%), with lower rates of moderate to severe aortic regurgitation (3.1% vs 5.4%).…”
Section: Outcome At 30 Daysmentioning
confidence: 99%
See 1 more Smart Citation
“…Four studies [8][9][10][11], for a total of 3,065 patients, reported the unadjusted rates of early outcomes by sex. Women experienced higher rates of major vascular complications (12.0% vs 7.4%) and of major and life-threatening bleeding (21.0% vs 13.0%), with lower rates of moderate to severe aortic regurgitation (3.1% vs 5.4%).…”
Section: Outcome At 30 Daysmentioning
confidence: 99%
“…In this setting, the effect of gender may be relevant to understand timing and opportunity of percutaneous intervention, but only a limited number of studies, reporting variable results, have investigated genderspecific differences in outcome after TAVI [9][10][11][12][13][14][15][16][17]. A recent meta-analysis on the same topic reported better short-term and midterm survival for women.…”
mentioning
confidence: 98%
“…21,22 The PARTNER trial also suggested that TAVR was associated with lower mortality than SAVR among women. [23][24][25] [23][24][25] …”
Section: Discussionmentioning
confidence: 99%
“…Available data suggests that female patients are at higher risk of bleeding and vascular complications (4,5) resulting in increased rehospitalization and mortality rates as compared to male subjects (6,7). In contrast, other studies report on either improved female or gender neutral survival rates after TAVR (8)(9)(10)(11).…”
mentioning
confidence: 85%